CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens

Tsuyoshi Ishii(Toho University), Tomohiro Kawamoto(Takeda (Japan))
Scientific Reports
October 5, 2017
Cited by 49


Related Papers